Extra- and Intracellular Mechanisms of Changes in Erythrocyte Aggregation

Abstract

Reversible aggregation is a form of erythrocyte behavior. The presence of α- and β-adrenergic receptors on erythrocyte membranes suggests that aggregation can be influenced by agonists of these receptors. Human erythrocyte aggregation (EA) was studied in the presence of α- and β-agonists of adrenergic receptors (in the concentration range from 10−6 to 10−8 M). The α2-agonist clonidine stimulated EA most strongly (by 163%, P < 0.01). The cell reaction decreased from the α-agonist clonidine to the β-agonist metaproterenol. The phosphodiesterase inhibitor papaverine and the penetrating cAMP analogue dibutyryl cAMP (dB-cAMP) increased the intracellular cAMP and decreased EA by 46–50% (P < 0.05). Clonidine-induced stimulation of EA sharply decreased upon erythrocyte incubation in the presence of clonidine + dB-cAMP and became even lower than in the control. Thus, α-agonists of adrenergic receptors markedly stimulated EA. The adenylate cyclase-cAMP system is likely involved as an intracellular signaling pathway.